課程介紹
 |
| ASCO 2024 Updates in the Treatment of Renal Cell Carcinoma and Evolving Data on Non-Clear Cell Renal Cell Carcinoma Martin H. Voss, MD, and Moshe C. Ornstein, MD, review significant renal cell carcinoma research developments presented at ASCO 2024, highlighting data and insights poised to reshape the disease's treatment landscape. Watch Now |
|
Featured Video |
%20(4).png?width=580&upscale=true&name=Marketing%20Image%20(6)%20(4).png) |
| TKIs, Disease Progression and Subsequent Therapy in RCC Key opinion leaders examine the application of tyrosine kinase inhibitors (TKIs) and evaluate first-line therapeutic approaches for renal cell carcinoma. Watch Now |
%20(1)%20(1)%20(3).png?width=600&upscale=true&name=MicrosoftTeams-image%20(16)%20(1)%20(1)%20(3).png) |